Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P1257: MOLECULAR CHARACTERIZATION AND CLONAL EVOLUTION OF MYCOSIS FUNGOIDES.

Autor: Fléchon, L., Arib, I., Dutta, A., Sklanvenitis Pistofidis, R., Stewart, C., Dubois, R., Poulain, S., Copin, M.‐C., Javed, S., Nudel, M., Hasan Bou Issa, L., Ouelkite‐Oumouchal, A., Faiz, S., Carpentier, O., Mortier, L., Mitra, S., Figeac, M., Morschhauser, F., Quesnel, B., Ghobrial, I.

Publikováno v: HemaSphere; 2022 Supplement 3, Vol. 6, p1142-1143, 2p

Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.

Autor: Fléchon L; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France., Arib I; Department of Hematology, Lille Hospital, Lille, France., Dutta AK; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.; Department of Medical Oncology, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA., Hasan Bou Issa L; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France., Sklavenitis-Pistofidis R; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.; Department of Medical Oncology, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA., Tilmont R; Department of Hematology, Lille Hospital, Lille, France., Stewart C; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA., Dubois R; Department of Pathology, Lille Hospital, Lille, France., Poulain S; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Department of Hematology, Biology and Pathology Center, Lille Hospital, Lille, France., Copin MC; Department of Pathology, Angers University, Angers Hospital, INSERM, CRCI2NA, Angers, France., Javed S; Department of Medical Oncology, Valenciennes Hospital, Valenciennes, France., Nudel M; Department of Hematology, Lille Hospital, Lille, France., Cavalieri D; Department of Hematology, Lille Hospital, Lille, France., Escure G; Department of Hematology, Lille Hospital, Lille, France., Gower N; Department of Hematology, Lille Hospital, Lille, France., Chauvet P; Department of Hematology, Lille Hospital, Lille, France., Gazeau N; Department of Hematology, Lille Hospital, Lille, France., Saade C; Department of Hematology, Lille Hospital, Lille, France., Thiam MB; Department of Hematology, Lille Hospital, Lille, France., Ouelkite-Oumouchal A; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France., Gaggero S; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France., Cailliau É; Department of Biostatistics, Lille Hospital, Lille, France., Faiz S; Department of Pathology and Dermatology, Lille Hospital, Lille, France., Carpentier O; Department of Pathology and Dermatology, Lille Hospital, Lille, France., Duployez N; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Department of Hematology, Biology and Pathology Center, Lille Hospital, Lille, France., Idziorek T; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France., Mortier L; Department of Pathology and Dermatology, Lille Hospital, Lille, France.; OncoThai unit, INSERM UMR-S1189, Lille University, Lille, France., Figeac M; Lille University, Lille Hospital, CNRS, INSERM, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, Lille, France., Preudhomme C; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Department of Hematology, Biology and Pathology Center, Lille Hospital, Lille, France., Quesnel B; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Department of Hematology, Lille Hospital, Lille, France., Mitra S; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France., Morschhauser F; Department of Hematology, Lille Hospital, Lille, France., Getz G; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Ghobrial IM; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.; Department of Medical Oncology, Harvard Medical School, Boston, MA.; Harvard Medical School, Boston, MA., Manier S; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Department of Hematology, Lille Hospital, Lille, France.

Publikováno v: Blood advances [Blood Adv] 2024 Jun 25; Vol. 8 (12), pp. 3109-3119.